Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TGen Clinical Research Services (TCRS) is a specialized clinical research organization and partnership between the Translational Genomics Research Institute (TGen) and HonorHealth. Based in Scottsdale, Arizona, TCRS is dedicated to the rapid translation of genomic discoveries into new treatments for patients with advanced cancers and other life-threatening diseases. The center operates primarily out of the Virginia G. Piper Cancer Center, where it conducts Phase I and Phase II clinical trials for novel therapeutic agents, including targeted small molecules, peptides, and immunotherapies. By leveraging TGen's advanced genomic sequencing and molecular profiling capabilities, TCRS provides a personalized approach to clinical trial design and patient selection. The organization serves as a critical bridge between laboratory research and clinical application, collaborating with global pharmaceutical and biotechnology partners to advance the next generation of precision medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on T-Gen Clinical Research Services.